Oppenheimer Asset Management Inc. Bausch Health Companies Inc. Transaction History

Oppenheimer Asset Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$7.06 - $23.63 $48,361 - $161,865	-6,850 Reduced 12.95%	46,030 $385,000
Q1 2022 May 12, 2022	BUY	$21.6 - $27.79 $691 - $889	32 Added 0.06%	52,880 $1.21 Million
Q4 2021 Feb 02, 2022	SELL	$23.0 - $29.01 $47,541 - $59,963	-2,067 Reduced 3.76%	52,848 $1.46 Million
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $53,034 - $63,667	-2,118 Reduced 3.71%	54,915 $1.53 Million
Q2 2021 Aug 03, 2021	BUY	$27.43 - $32.7 $16,979 - $20,241	619 Added 1.1%	57,033 $1.67 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $2,179 - $3,506	-102 Reduced 0.18%	56,414 $1.79 Million
Q4 2020 Feb 11, 2021	BUY	$15.31 - $21.12 $182,433 - $251,665	11,916 Added 26.72%	56,516 $1.18 Million
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $218,855 - $296,072	14,708 Added 49.2%	44,600 $693,000
Q2 2020 Aug 11, 2020	BUY	$13.31 - $20.51 $211,442 - $325,821	15,886 Added 113.42%	29,892 $547,000
Q1 2020 May 08, 2020	SELL	$12.98 - $30.25 $380,041 - $885,689	-29,279 Reduced 67.64%	14,006 $217,000
Q4 2019 Feb 07, 2020	BUY	$18.89 - $31.89 $817,653 - $1.38 Million	43,285 New	43,285 $1.3 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.